Unknown

Dataset Information

0

Predicting meaningful outcomes to medication and self-help treatments for binge-eating disorder in primary care: The significance of early rapid response.


ABSTRACT: We examined rapid response among obese patients with binge-eating disorder (BED) in a randomized clinical trial testing antiobesity medication and self-help cognitive-behavioral therapy (shCBT), alone and in combination, in primary-care settings.One hundred four obese patients with BED were randomly assigned to 1 of 4 treatments: sibutramine, placebo, shCBT + sibutramine, or shCBT + placebo. Treatments were delivered by generalist primary-care physicians and the medications were given double-blind. Independent assessments were performed by trained and monitored doctoral research clinicians monthly throughout treatment, posttreatment (4 months), and at 6- and 12-month follow-ups (i.e., 16 months after randomization). Rapid response, defined as ?65% reduction in binge eating by the fourth treatment week, was used to predict outcomes.Rapid response characterized 47% of patients, was unrelated to demographic and baseline clinical characteristics, and was significantly associated, prospectively, with remission from binge eating at posttreatment (51% vs. 9% for nonrapid responders), 6-month (53% vs. 23.6%), and 12-month (46.9% vs. 23.6%) follow-ups. Mixed-effects model analyses revealed that rapid response was significantly associated with greater decreases in binge-eating or eating-disorder psychopathology, depression, and percent weight loss.Our findings, based on a diverse obese patient group receiving medication and shCBT for BED in primary-care settings, indicate that patients who have a rapid response achieve good clinical outcomes through 12-month follow-ups after ending treatment. Rapid response represents a strong prognostic indicator of clinically meaningful outcomes, even in low-intensity medication and self-help interventions. Rapid response has important clinical implications for stepped-care treatment models for BED.clinicaltrials.gov: NCT00537810 (PsycINFO Database Record

SUBMITTER: Grilo CM 

PROVIDER: S-EPMC4380674 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Predicting meaningful outcomes to medication and self-help treatments for binge-eating disorder in primary care: The significance of early rapid response.

Grilo Carlos M CM   White Marney A MA   Masheb Robin M RM   Gueorguieva Ralitza R  

Journal of consulting and clinical psychology 20150126 2


<h4>Objective</h4>We examined rapid response among obese patients with binge-eating disorder (BED) in a randomized clinical trial testing antiobesity medication and self-help cognitive-behavioral therapy (shCBT), alone and in combination, in primary-care settings.<h4>Method</h4>One hundred four obese patients with BED were randomly assigned to 1 of 4 treatments: sibutramine, placebo, shCBT + sibutramine, or shCBT + placebo. Treatments were delivered by generalist primary-care physicians and the  ...[more]

Similar Datasets

| S-EPMC4446220 | biostudies-literature
| S-EPMC3757519 | biostudies-literature
| S-EPMC4026932 | biostudies-literature
| S-EPMC3290797 | biostudies-literature
| S-EPMC8010989 | biostudies-literature
| S-EPMC3041988 | biostudies-literature
| S-EPMC8579466 | biostudies-literature
| S-EPMC3962509 | biostudies-literature
| S-EPMC2880825 | biostudies-literature